Skip to main content

Adeno-Associated Virus Delivery of Viral Serpins for Ocular Diseases: Design and Validation

  • Protocol
  • First Online:
Serpins

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1826))

Abstract

Adeno-associated virus (AAV) has become the preferred viral gene transfer platform for ocular gene therapy due to its known safety profile in human clinical trials. This viral vector has a 4.7 kbp (kilo base pair) carrying capacity (single-stranded DNA) and only retains the inverted terminal repeats (ITRs) from the original virus. Here we describe the design and testing of AAV vectors capable of delivering an anti-inflammatory serine protease inhibitor (serpin) derived from the myxoma virus. Myxoma is a rabbit species specific virus infection, a Leporipoxvirus. Myxomaviral proteins have been developed as therapeutic stand-alone immune-modulating proteins for inflammation-based disorders and the myxoma virus itself is under development as a viral oncolytic platform for cancer treatment. We fused the Serp2 gene with the GFP reporter gene through a self-cleaving peptide.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hastie E, Samulski RJ (2015) Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success—a personal perspective. Hum Gene Ther 26:257–265. https://doi.org/10.1089/hum.2015.025

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Cideciyan AV, Hauswirth WW, Aleman TS et al (2009) Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther 20:999–1004. https://doi.org/10.1089/hum.2009.086

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. MacLaren RE, Groppe M, Barnard AR et al (2014) Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet 383:1129–1137. https://doi.org/10.1016/S0140-6736(13)62117-0

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Datta S, Cano M, Ebrahimi K et al (2017) The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res 60:201–218. https://doi.org/10.1016/j.preteyeres.2017.03.002

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Xu H, Chen M (2017) Diabetic retinopathy and dysregulated innate immunity. Vision Res 139:39–46. https://doi.org/10.1016/j.visres.2017.04.013

    Article  PubMed  Google Scholar 

  6. Dick AD (2017) Doyne lecture 2016: intraocular health and the many faces of inflammation. Eye (Lond) 31:87–96. https://doi.org/10.1038/eye.2016.177

    Article  CAS  Google Scholar 

  7. van Gent D, Sharp P, Morgan K, Kalsheker N (2003) Serpins: structure, function and molecular evolution. Int J Biochem Cell Biol 35:1536–1547. https://doi.org/10.1016/S1357-2725(03)00134-1

    Article  PubMed  CAS  Google Scholar 

  8. Turner PC, Sancho MC, Thoennes SR et al (1999) Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1β-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells. J Virol 73:6394–6404

    PubMed  PubMed Central  CAS  Google Scholar 

  9. Messud-Petit F, Gelfi J, Delverdier M et al (1998) Serp2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. J Virol 72:7830–7839

    PubMed  PubMed Central  CAS  Google Scholar 

  10. Viswanathan K, Bot I, Liu L et al (2012) Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro. PLoS One 7:e44694. https://doi.org/10.1371/journal.pone.0044694

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Kozak M (1987) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells.J Mol Biol 196:947–950. https://doi.org/10.1016/0022-2836(87)90418-9

  12. Kim JH, Lee S-R, Li L-H et al (2011) High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 6:e18556. https://doi.org/10.1371/journal.pone.0018556

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685

    Article  CAS  PubMed  Google Scholar 

  14. Boussif O, Lezoualc’h F, Zanta MA et al (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 92:7297–7301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ehrhardt C, Schmolke M, Matzke A et al (2006) Polyethylenimine, a cost-effective transfection reagent. Signal Transduct 6:179–184. https://doi.org/10.1002/sita.200500073

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristhian J. Ildefonso .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Ildefonso, C.J., Lewin, A.S. (2018). Adeno-Associated Virus Delivery of Viral Serpins for Ocular Diseases: Design and Validation. In: Lucas, A. (eds) Serpins. Methods in Molecular Biology, vol 1826. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8645-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8645-3_16

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-8644-6

  • Online ISBN: 978-1-4939-8645-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics